Feasibility of discontinuing immunosuppression in children with idiopathic nephrotic syndrome
ConclusionsLong-term discontinuation of immunosuppressants can be feasible in patients without a relapse on initial immunosuppressants, those with longer relapse-free interval before discontinuation of immunosuppressants, and those without a relapse for one year after discontinuation of immunosuppressants.Trial registrationNot applicable.Graphical abstractA higher resolution version of the Graphical abstract is available asSupplementary information
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Children | Genetics | Nephrotic Syndrome | Pediatrics | Rituxan | Study | Urology & Nephrology